Development, impact and outcomes of the Hull Bacteraemia Service

QJM. 2008 Nov;101(11):889-98. doi: 10.1093/qjmed/hcn114. Epub 2008 Sep 19.

Abstract

Background: Bacteraemia is a significant cause of mortality and healthcare expenditure. Evidence suggests that consultation by an infection specialist may improve outcomes.

Aim: To review the characteristics and outcomes of patients seen by a newly implemented bacteraemia service.

Methods: Retrospective review of data collected at time of consultation. Economic analyses and benchmarking of outcomes were also performed.

Results: One hundred and fifty-one patients were seen by the service over an 18-month period. Staphylococcus aureus was the most common isolate and central venous lines the most common source. Antibiotics were changed and additional investigations suggested in 62% and 61% of patients, respectively. The 30-day mortality was 19%. Implementation and delivery of the service over the 18-month study period cost pound 22,663 (pound 15,109 per year). The cost per change in antibiotic prescription was pound 244. The cost per 'near-miss' detected was pound 1193. Overall mortality was no higher and possibly lower than in published studies.

Conclusion: We believe that this model of care may be suitable for the management of patients with bacteraemia. A study assessing the cost-effectiveness of this approach is required.

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Anti-Bacterial Agents / economics
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia / drug therapy*
  • Bacteremia / mortality
  • Cost-Benefit Analysis
  • Delivery of Health Care / economics*
  • England
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pilot Projects
  • Program Development*

Substances

  • Anti-Bacterial Agents